Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siwang Yu

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Oncotarget|April 27, 2017
A novel triazolonaphthalimide induces apoptosis and inhibits tumor growth by targeting DNA and DNA-associated processesLiyan Ji, Simin Yang, Shasha Li, et al.
Chinese Medical Journal|April 18, 2023
Dose-response relationship between physical activity and nonalcoholic fatty liver disease: A prospective cohort studyPei Li, Qingqing Yang, Xinping Wang, et al.
Scientific Reports|April 12, 2016
TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cellsYonggang Ren, Lu Qiu, Fenglin Lü, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2023
Anemoside B4 attenuates RANKL-induced osteoclastogenesis by upregulating Nrf2 and dampens ovariectomy-induced bone lossZhen Cao, Xuben Niu, Maihuan Wang, et al.
Chemical Research in Toxicology|March 30, 2011
tBHQ-induced HO-1 expression is mediated by calcium through regulation of Nrf2 binding to enhancer and polymerase II to promoter region of HO-1Ka Lung Cheung, Siwang Yu, Zui Pan, et al.
Cancers|December 20, 2018
Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor RepressorLu Qiu, Meng Wang, Shaofan Hu, et al.
Molecular Carcinogenesis|January 25, 2024
SN-38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2-related factor 2 and enhances drug sensitivity of colorectal cancer cellsJingya Wang, Jiangli Xu, Shuhui Yang, et al.
Fitoterapia|February 4, 2014
Isoangustone A induces apoptosis in SW480 human colorectal adenocarcinoma cells by disrupting mitochondrial functionsWei Huang, Shunan Tang, Xue Qiao, et al.
Biochimica Et Biophysica Acta|July 1, 2008
Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motifWenge Li, Siwang Yu, Tong Liu, et al.
Biochemical Pharmacology|August 13, 2008
Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosisWenge Li, Tin Oo Khor, Changjiang Xu, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Oncotarget|April 27, 2017
A novel triazolonaphthalimide induces apoptosis and inhibits tumor growth by targeting DNA and DNA-associated processesLiyan Ji, Simin Yang, Shasha Li, et al.
Chinese Medical Journal|April 18, 2023
Dose-response relationship between physical activity and nonalcoholic fatty liver disease: A prospective cohort studyPei Li, Qingqing Yang, Xinping Wang, et al.
Scientific Reports|April 12, 2016
TALENs-directed knockout of the full-length transcription factor Nrf1α that represses malignant behaviour of human hepatocellular carcinoma (HepG2) cellsYonggang Ren, Lu Qiu, Fenglin Lü, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 9, 2023
Anemoside B4 attenuates RANKL-induced osteoclastogenesis by upregulating Nrf2 and dampens ovariectomy-induced bone lossZhen Cao, Xuben Niu, Maihuan Wang, et al.
Chemical Research in Toxicology|March 30, 2011
tBHQ-induced HO-1 expression is mediated by calcium through regulation of Nrf2 binding to enhancer and polymerase II to promoter region of HO-1Ka Lung Cheung, Siwang Yu, Zui Pan, et al.
Cancers|December 20, 2018
Oncogenic Activation of Nrf2, Though as a Master Antioxidant Transcription Factor, Liberated by Specific Knockout of the Full-Length Nrf1α that Acts as a Dominant Tumor RepressorLu Qiu, Meng Wang, Shaofan Hu, et al.
Molecular Carcinogenesis|January 25, 2024
SN-38, an active metabolite of irinotecan, inhibits transcription of nuclear factor erythroid 2-related factor 2 and enhances drug sensitivity of colorectal cancer cellsJingya Wang, Jiangli Xu, Shuhui Yang, et al.
Fitoterapia|February 4, 2014
Isoangustone A induces apoptosis in SW480 human colorectal adenocarcinoma cells by disrupting mitochondrial functionsWei Huang, Shunan Tang, Xue Qiao, et al.
Biochimica Et Biophysica Acta|July 1, 2008
Heterodimerization with small Maf proteins enhances nuclear retention of Nrf2 via masking the NESzip motifWenge Li, Siwang Yu, Tong Liu, et al.
Biochemical Pharmacology|August 13, 2008
Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosisWenge Li, Tin Oo Khor, Changjiang Xu, et al.
Pageof 8